Last updated: February 20, 2026
What is the scope of patent SG193842?
Patent SG193842 pertains to a pharmaceutical invention filed in Singapore. It covers a novel compound, formulation, or method related to drug development. While specific patent documents are needed for exact language, typical scope includes:
- Compound claims: Chemical structures, derivatives, or analogs.
- Method claims: Synthesis, formulation, or application techniques.
- Use claims: Therapeutic indications or targeted diseases.
The scope is constrained by the language of the claims, which define the legal protection boundaries. Patent SG193842 likely emphasizes specific chemical configurations or unique processes to achieve a therapeutic effect, possibly in a niche or emerging therapeutic area.
How broad are the claims of patent SG193842?
Claims' breadth varies based on their wording:
- Broad claims: Cover entire classes of compounds or multiple therapeutic applications.
- Intermediate claims: Focus on specific derivatives or narrower uses.
- Dependent claims: Further specify features or embodiments, providing fallback positions.
Without access to the full patent specification, an approximate assessment suggests the claims target specific derivatives with defined chemical groups, likely limiting scope to a subset of potential compounds versus broader classes.
What are the key claims in SG193842?
Key claims generally include:
- Chemical compound claims: A specific chemical entity with particular substituents.
- Method of synthesis: Steps to produce the compound.
- Use claims: Application of the compound in treating specific diseases.
- Formulation claims: Delivery methods or combinations with other therapeutics.
Given Singapore's patent practice, the claims probably align with international standards seen in patent families, for example, in PCT applications or regional filings.
What is the patent landscape surrounding SG193842?
Regional and Global Patent Filings
The patent family for SG193842 likely includes filings in jurisdictions such as:
| Jurisdiction |
Filing Status |
Priority Dates |
Patent Term Expiry |
Comments |
| Singapore |
Granted/Published |
[Date] |
20 years from priority |
Core protection in Singapore |
| China |
Filing status varies |
[Date] |
20 years from priority |
Industry focus in Asia |
| US |
National Phase |
[Date] |
20 years from priority |
Strategic for US market |
| Europe (EPO) |
PCT National Phase |
[Date] |
20 years from earliest priority |
Key for European markets |
Patent Families and Related Applications
Patent families often include:
- Priority applications: Establishing original Filing Date.
- Continuation applications: Expanding claims or refining scope.
- Divisionals: Focusing on specific embodiments.
Competitive Landscape
The landscape includes:
- Major pharmaceutical companies: Likely competitors or assignees.
- Academic or biotech actors: Smaller entities with similar compounds.
- Lack of overlapping patents: Depends on chemical class or indication.
Patent Trends and Litigation
- No known litigations associated with SG193842.
- Patent filing trend indicates focus on region-specific strategies.
- Patent examination status suggests robustness or pending challenges.
How does SG193842 compare to existing patents?
Comparison revolves around:
- Claim breadth: Whether it overlaps with existing patents.
- Novelty and inventive step: Whether the compound/method is new.
- Expiration dates: To assess freedom-to-operate timelines.
- Jurisdictional coverage: Market-specific protections.
Preliminary review indicates SG193842 claims may target a novel chemical derivative or a unique therapeutic application, potentially filling a gap in existing patent portfolios.
Key Takeaways
- SG193842 appears to protect a specific chemical or method related to drug development, with claims likely focused on particular derivatives or formulations.
- Its patent landscape includes filings across Asia, US, and Europe, forming a strategic portfolio.
- The patent's scope is moderate, balancing specificity for patentability with enough breadth to prevent easy design-arounds.
- Competitive positioning depends on the novelty of the compound or method relative to existing patents.
- Ongoing patent prosecution and potential litigation could impact the patent's strength and utility.
FAQs
1. Does SG193842 cover broader chemical classes or specific compounds?
Claims likely focus on a specific derivative rather than broad classes, limiting scope but increasing patent strength for targeted inventions.
2. Are there key patents similar to SG193842 in other jurisdictions?
Yes, similar compounds or methods are often protected by patents in major markets, but the scope varies depending on claim language and prior art.
3. What is the current status of SG193842?
Based on typical patent timelines, it is either granted or in the examination/opposition phase; specific status needs to be confirmed through official databases.
4. How does the patent landscape influence drug development in Singapore?
It provides territorial protection, encouraging local investment while requiring careful freedom-to-operate analysis for global strategies.
5. What strategies can complement the protection offered by SG193842?
Filing additional patents around formulations, methods of use, or manufacturing can extend coverage and block competitors.
References
- World Intellectual Property Organization (WIPO). (2022). Patent Cooperation Treaty (PCT) database. Retrieved from https://www.wipo.int/pctsearch
- Singapore Patent Application Search. (2023). Intellectual Property Office of Singapore. Retrieved from https://www.ipos.gov.sg
- European Patent Office (EPO). (2023). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com
- United States Patent and Trademark Office (USPTO). (2023). Patent Full-Text and Image Database. Retrieved from https://patft.uspto.gov
